# 2.4.8. Potential Buyers

The **Medimint Token (MDMT)** appeals to a diverse spectrum of buyers, each deriving unique\
value from its real world healthcare integration and blockchain backed utility. <br>

**Institutional Investors** such as healthcare venture funds, impact investors, and blockchainfocused funds are drawn to MDMT as a real world asset (RWA) backed by diagnostic equipment and verifiable data streams. The token’s deflationary design, profit sharing model,\
and sustainable yield mechanisms make it an attractive addition to institutional portfolios\
seeking long term, impact driven returns in digital health infrastructure.

\
**Retail Investors** benefit from early participation in a project with tangible utility and consistent\
yield potential. By staking MDMT tokens, individual investors can earn passive income while\
supporting the decentralization of global healthcare infrastructure. This combination of\
accessibility and transparency aligns with the growing interest in tokens that generate verifiable\
real world value rather than speculative hype.

\
**Hospitals and Diagnostic** Centers form the operational backbone of the Medimint ecosystem.\
By holding MDMT, they can access discounted diagnostic services, earn rewards for machine\
data contributions, and utilize tokens for software upgrades or ecosystem integrations.

\
**Pharma Companies and Research Firms** can purchase MDMT tokens to access anonymized,\
aggregated diagnostic datasets for drug discovery, trial optimization, and biomarker research.\
Meanwhile, AI based healthcare startups and data analysts can use these datasets to\
develop, test, and validate algorithms for predictive diagnostics and personalized treatment\
models.

\
Collectively, these buyers contribute to a self sustaining healthcare economy where\
innovation, transparency, and tokenized ownership coexist to transform global healthcare\
delivery.
